(MENAFN- ProactiveInvestors) A strong start by US equities fuelled by Fed-induced optimism meant London’s top share index closed higher.
FTSE 100 banked triple digit gains rising 130 to 6466 as good vibes from Wednesday’s Federal Reserve announcement were carried over to the second day.
A combination of commodity stocks and financials were at the forefront as the oil price ticked up and global macro concerns eased.
Drinks group was a standout riser up 5.6% as the South African firm benefited from a rise in the rand currency. For much the same reason South African insurance company () shot up 5.7%.
owner IAG climbed higher as reports emerged that it might bid for Irish airline Aer Lingus.
There wasn’t much in the way of company announcements but Group gained 4% as it reported figures for the first 11 months of the year.
The bourse showed a 54% increase in the amount of equity capital raised on its markets.
Black Friday shopping fever helped UK retail sales to grow at their fastest annual rate in more than 10 years in November.
That pushed London’s blue chip retailers higher including Next and . and 's also made gains.
In the AIM world () shot up 25% as () posted a significant increase in its internal resource estimate for the southern part of the Ruvuma gas project in Tanzania. Solo has a 25% interest in Ruvuma.
() gained 14%. The firm says it has found extraordinary copper grades from its latest drill holes at Picachos in Chile.
Shares in smart metering solutions provider Cyan () were firmly in the blue up 7.1% after it announced an order from Brazil.
( TSX:CAZ) unveiled ‘excellent’ results from its two latest wells in Lea County New Mexico. Shares were up 12%.
REX Bionics () saw its share price halve as the company admitted it will need to provide clinical data to build sales momentum for its revolutionary but expensive robotic exoskeleton technology.
Elsewhere in the healthcare world it was a happier story for () the designer and manufacturer of rapid diagnostic and screening products.
Shares rose 2.5p to 225p as the company entered into multi-year distribution agreements for its PIFA Heparin/PF4 Rapid Assay products with Cryopep SARL covering France Belgium the Netherlands and Luxembourg; and DiaLine AG covering Switzerland and Lichtenstein.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.